Clinical trial
Individualized Navigated Photothermal Therapy in Patients With Intermediate AMD: A Randomized, Double-Blinded, Controlled Clinical Trial to Evaluate the Performance of theTherapy Proposed by Macula Explorer Using Navilas Laser System
NCT07607496 is registered in ClinicalTrials.gov with OD-OS MacuTherm GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Individualized Navigated Photothermal Therapy in Patients With Intermediate AMD: A Randomized, Double-Blinded, Controlled Clinical Trial to Evaluate the Performance of theTherapy Proposed by Macula Explorer Using Navilas Laser System
- Lead sponsor
- OD-OS MacuTherm GmbH
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 29, 2026
- Completion date
- December 31, 2028
- Enrollment
- 240 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
intermediate amd